Skip to main content
Contact Us
Sign Up
Subscriber Sign In
navigation
サイト内検索
What We Do
Commercial Intelligence
Products
Evaluate Pharma
Evaluate Omnium
Evaluate Medtech
Evaluate Epi
Japan Drug Forecasts
Europe Drug Forecasts
Pharma Consulting & Analytics
Pharma Consulting & Analytics
Data Feeds and APIs
Evaluate Vantage
News
Analysis
Policy & Pricing
Insights
Events
Medtech
Therapy Areas
Editorial Team
About Evaluate Vantage
Evaluate for Biotech
How We Can Help You
Pharma and Biotech
Financial Services
Management Consultancies
Service Providers
Customer Testimonials
Thought Leadership
Multimedia
Blog
About Us
Press Releases
Media Coverage
Executive Team
Vision & History
Contact Us
Sign Up for Evaluate Vantage
Talent
Subscriber Sign In
Search
Open configuration options
Search
Vantage
Covid-19
Covid-19 Coverage
Evaluate Vantage COVID-19 Report
News
Snippets
Deals
Trial results
Patents and litigation
Corporate strategy
Analysis
Interviews
Spotlight
Vantage points
Vantage views
Insights
M&A
IPO
NME approvals
Quarterly shareprice performance
Venture financing
Vantage data points
Other data
Events
Company events
Conferences
Upcoming events
Medtech
Therapy Areas
About
Editorial team
Breadcrumb
Home
Vantage
Articles
Data Insights
Vantage Data Points
Share Price Movers October 2019
November 04, 2019
Share price movers – October 2019
Edwin Elmhirst
Vantage Data Points
Related Companies
Achillion Pharmaceuticals
Assembly Biosciences
Botanix Pharmaceuticals
Constellation Pharmaceuticals
Cyclerion Therapeutics
Kiadis Pharma
Ra Pharmaceuticals
Reata Pharmaceuticals
ReNeuron Group
Savara Pharmaceuticals
Download PDF
Share This Article
We use cookies on this website. By using this site, you agree that we may store and access cookies on your device.
Find out more.
OK
Independent, data-driven daily news and analysis on pharma, biotech and medtech.
Sign up
Latest Reports
July 04, 2022
Pharma Drivers eBook Part 1
June 16, 2022
Vantage Top 10 Most Read Report
Related Articles
October 16, 2019
Alexion pays Achillion a $930m complement
October 10, 2019
UCB goes to Ra for a complementary approach
August 06, 2019
Share price movers – July 2019
July 03, 2019
Share price catalysts: June 2019
December 18, 2018
Achillion’s first oral Soliris rival hits the buffers
Editor's Picks
June 14, 2022
Roche deal fails to Repare the licensing scene
June 13, 2022
EHA 2022 – Crispr still looks bloody good
June 05, 2022
Asco 2022 – Enhertu asks, how low can you go?
June 09, 2022
Asco 2022 movers – cell therapy wins, but it’s not the whole story
May 30, 2022
Abbvie to become the biggest of pharmas in 2028